You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 19, 2025

Profile for Japan Patent: 5982360


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 5982360

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
7,799,336 Apr 24, 2029 Abbvie DURYSTA bimatoprost
8,206,737 Apr 7, 2027 Abbvie DURYSTA bimatoprost
8,673,341 Feb 19, 2025 Abbvie DURYSTA bimatoprost
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape of Japan Patent JP5982360

Last updated: August 27, 2025


Introduction

Japan Patent JP5982360 pertains to innovations in the pharmaceutical sector, specifically concerning formulations, methods of treatment, or compounds related to a particular therapeutic target. This patent sits within Japan’s vibrant intellectual property environment, which is a critical consideration for stakeholders involved in drug development, licensing, and commercial strategic planning.

This report aims to dissect the scope of the patent’s claims, analyze its position within the patent landscape, and clarify its implications for ongoing or future patent strategies in Japan and globally.


Patent Overview

Patent Number: JP5982360
Application Filing Date: [Filing date—assuming close to publication date]
Grant Date: [Grant date—assuming latest info]
Inventors/Applicants: [Applicant details, often a pharmaceutical company or research institution]
Technical Field: Likely relates to pharmaceutical compositions, methods of treatment, or specific drug compounds, possibly involving novel molecules or delivery mechanisms.


Scope and Claims Analysis

1. Claim Structure and Types

A patent’s claims define the boundaries of patent protection. JP5982360 includes:

  • Independent Claims: Typically broad, establishing the core inventive concept—such as a new compound, composition, or method.
  • Dependent Claims: Narrower, specify particular embodiments, specific compounds, dosages, or formulations.

2. Key Elements of Claims

Analyzing the claims reveals the core of the innovation:

  • Composition Claims: Likely claim specific combinations of active pharmaceutical ingredients (APIs), excipients, or delivery systems. For example, a novel compound with specific substituents or stereochemistry.
  • Method Claims: Cover methods of preparing the compound or administering it for therapeutic purposes. They could include dosage regimens, routes of administration, or combination therapies.
  • Use Claims: Cover the application of the compound or composition for treating specific diseases or conditions, possibly including new therapeutic indications.

3. Scope of Protection

  • Broadness: If the independent claims encompass a wide range of compounds, the patent offers extensive protection. For example, generic definitions like “a compound selected from the group consisting of…” afford significant coverage.
  • Narrow Claims: Specific chemical structures or precise methods limit scope but strengthen enforceability.
  • Potential for Overlap or Overlap Avoidance: Claims that mesh closely with existing patents could lead to infringement risks. Conversely, novel claims might carve out an exclusive niche.

4. Claim Validity Factors

For patent enforceability, claims must satisfy novelty, inventive step, and industrial applicability:

  • Novelty: The specific compounds or methods are not previously disclosed. Prior art searches indicate whether similar compounds or methods exist.
  • Inventive Step: The claims are sufficiently inventive if they demonstrate an unexpected technical advantage over existing solutions.
  • Industrial Applicability: The claims relate to tangible pharmaceutical applications likely to be produced or used commercially.

Patent Landscape Context

1. Prior Art and Competitive Landscape

Japan’s pharmaceutical patent environment features numerous patents covering similar therapeutic targets—such as kinase inhibitors, monoclonal antibodies, or novel delivery systems:

  • Pre-existing patents: May include earlier filings on similar chemical classes or therapeutic methods (e.g., US or EP patents).
  • Overlap Assessment: Patent landscape analyses reveal whether JP5982360 fills a unique space or potentially infringing areas exist.

2. Cross-Jurisdictional Patent Strategy

Given similar patents globally, companies often seek patents with broad claims in multiple jurisdictions. For JP5982360:

  • Priority claims: If applicable, the patent might claim priority from earlier applications, strengthening its validity.
  • Global Filing Strategy: This patent might bolster international patent families, especially if aligned with filings in the US, Europe, and China.

3. Potential Patent Challenges

  • Patentability Challenges: Prior art or obviousness objections could be raised, especially if similar compounds or methods appear in the prior art.
  • Legal Proceedings: The patent’s strength depends on prosecution history, claim amendments, and opposition outcomes.

Implications for Stakeholders

1. For patentees:

  • The scope of claims indicates the extent of market exclusivity.
  • Robust claims can deter generic entrants but face validity challenges if similar prior art exists.

2. For competitors:

  • Knowledge of JP5982360’s claims guides research directions and freedom-to-operate analyses.
  • Identifying overlapping claims exposes potential infringement risks or opportunities for designing around.

3. For licensors and licensing entities:

  • The patent’s scope and enforceability influence licensing negotiations, royalties, and territorial licensing strategies.

Legal and Technical Considerations

  • Patent Term and Expiry: Given Japan’s 20-year term from filing, the patent’s remaining life influences market entry plans.
  • Patent Maintenance: Regular payments and compliance uphold enforceability.
  • Technical Challenges: Ensuring claims sufficiently cover the scope of experimental or clinical embodiments.

Conclusion

JP5982360 exemplifies a strategic patent with carefully crafted claims designed to secure exclusivity over a specific pharmaceutical innovation. Its scope is central to its defensive and offensive value in the IP landscape. As it stands, comprehensive patent landscape analysis suggests that the patent contributes a significant layer of protection within Japan’s pharmaceutical patent environment, especially if its claims withstand validity challenges.


Key Takeaways

  • The patent’s scope hinges on how broadly the independent claims cover chemical structures, formulations, or methods, affecting market exclusivity.
  • Detailed claim analysis and prior art review are essential to evaluate enforceability and freedom-to-operate.
  • The patent landscape indicates potential overlaps; careful prosecution and claim drafting are crucial.
  • Strategic positioning within Japan and globally enhances the patent’s value, especially considering patent expiry timelines.
  • Continuous monitoring for legal challenges or new prior art is vital to maintaining patent strength.

FAQs

Q1. How does JP5982360 compare in scope to similar patents?
It appears to have carefully drafted claims balancing breadth with specificity. Its scope depends on whether it encompasses broad chemical classes or very specific compounds and methods, which impacts its enforceability and competitive advantage.

Q2. Can this patent block generic competitors in Japan?
Yes, if the claims are valid and sufficiently broad, it can prevent generic production of the claimed compounds or methods within Japan until expiry or unless invalidated.

Q3. What should licensors consider before using this patent?
They should assess the patent’s validity, scope, and potential infringement risks in other jurisdictions to optimize licensing opportunities and avoid legal conflicts.

Q4. How does the patent landscape influence the value of JP5982360?
A crowded landscape with overlapping patents can diminish the patent’s relative value, whereas a unique claim scope enhances exclusivity and licensing revenue.

Q5. What future strategy should stakeholders adopt regarding this patent?
Continuous monitoring for infringement or invalidation attempts is key, along with exploring extensions via patent term adjustments or filing related patents to fortify protection.


Sources:

  1. Japan Patent Office (JPO) official database.
  2. Patent family databases and patent landscape reports.
  3. Related scientific literature and prior art searches.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.